ICU Medical
ICUI
156.03
-3.70
-2.32%
ICU Medical
US · ICUI
#2287 by market cap
Listed 1970
156.03
-3.70
-2.32%
Live - 5344 symbols - heartbeat 175s ago
· 2026-10-07 19:54
After-hours
156.03
0.00%
- Market cap
- 3.90B
- P/E (TTM)i
- 131.12
- P/Bi
- 1.81
- EPSi
- 0.03
- Div yieldi
- 0.00%
- 52W posi
- 54%
Reader sentiment
Are you bullish or bearish on ICUI?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 5 analysts
Buy
Avg price target
191.40 +22.7%
Price target rangecurrent 156.03
Low175.00
Avg191.40
High200.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-23 | Piper Sandler | -- | BUY | 195.00 |
| 2026-09-18 | Piper Sandler | -- | BUY | 195.00 |
| 2026-08-07 | Piper Sandler | -- | BUY | 195.00 |
| 2026-08-07 | Raymond James | -- | BUY | 200.00 |
| 2026-08-07 | BTIG | -- | BUY | 200.00 |
| 2026-08-07 | Needham | -- | BUY | 187.00 |
| 2026-07-16 | Jefferies | -- | BUY | 175.00 |
| 2026-06-15 | BTIG | -- | BUY | 170.00 |
| 2026-06-10 | Piper Sandler | -- | BUY | 163.00 |
| 2026-05-27 | Needham | -- | BUY | 165.00 |
| 2026-05-08 | Piper Sandler | -- | BUY | 163.00 |
| 2026-05-08 | KeyBanc | -- | BUY | 164.00 |
| 2026-05-08 | Needham | -- | HOLD | -- |
| 2026-05-04 | Piper Sandler | -- | BUY | 163.00 |
| 2026-04-27 | KeyBanc | -- | BUY | 164.00 |
| 2026-04-17 | Piper Sandler | -- | BUY | 163.00 |
| 2026-04-14 | Needham | -- | HOLD | -- |
| 2026-03-17 | Piper Sandler | -- | BUY | 178.00 |
| 2026-02-20 | Piper Sandler | -- | BUY | 178.00 |
| 2026-02-20 | KeyBanc | -- | BUY | 180.00 |
| 2026-02-20 | Needham | -- | HOLD | -- |
| 2026-02-18 | Piper Sandler | -- | BUY | 172.00 |
| 2026-01-25 | KeyBanc | -- | BUY | 175.00 |
| 2025-12-04 | KeyBanc | -- | BUY | 175.00 |
| 2025-11-07 | Piper Sandler | -- | BUY | 172.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Hold
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 1 upgrade vs 0 downgrades among tracked analyst rating changes.
- Most recent: Needham moved from Hold to Buy on 2026-05-27.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-05-27 | Needham | HOLD → BUY | 165.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-06 | After close | ±8.32% | +10.93% (beat) |
| 2026/Q1 | 2026-05-07 | After close | ±6.97% | +2.73% (in line) |
| 2025/Q4 | 2026-02-19 | After close | ±10.81% | +4.87% (in line) |
| 2025/Q3 | 2025-11-06 | After close | ±10.34% | +8.09% (in line) |
| 2025/Q2 | 2025-08-07 | After close | ±12.21% | -13.13% (beat) |
| 2025/Q1 | 2025-05-08 | After close | -- | -3.20% |
| 2024/Q4 | 2025-02-27 | After close | ±12.15% | -2.28% (in line) |
| 2024/Q3 | 2024-11-12 | After close | ±14.17% | -1.80% (in line) |
| 2024/Q2 | 2024-08-07 | After close | -- | +24.27% |
| 2024/Q1 | 2024-05-07 | After close | ±22.79% | -1.15% (in line) |
| 2023/Q4 | 2024-02-27 | After close | -- | +5.31% |
| 2023/Q3 | 2023-11-06 | After close | ±15.97% | -17.31% (beat) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.